Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0624620200530040212
BMB Reports
2020 Volume.53 No. 4 p.212 ~ p.217
15d-PGJ2 inhibits NF-¥êB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism
Jang Hye-Yeon

Hong On-Yu
Youn Hyun-Jo
Kim Min-Gul
Kim Cheorl-Ho
Jung Sung-Hoo
Kim Jong-Suk
Abstract
Activation of peroxisome proliferator-activated receptor ¥ã (PPAR¥ã) serves as a key factor in the proliferation and invasion of breast cancer cells and is a potential therapeutic target for breast cancer. However, the mechanisms underlying this effect remain largely unknown. Heme oxygenase-1 (HO-1) is induced and overexpressed in various cancers and is associated with features of tumor aggressiveness. Recent studies have shown that HO-1 is a major downstream target of PPAR¥ã. In this study, we investigated the effects of induction of HO-1 by PPAR¥ã on TPAinduced MMP-9 expression and cell invasion using MCF-7 breast cancer cells. TPA treatment increased NF-¥êB /AP-1 DNA binding as well as MMP-9 expression. These effects were significantly blocked by 15d-PGJ2, a natural PPAR¥ã ligand. 15d-PGJ2 induced HO-1 expression in a dose-dependent manner. Interestingly, HO-1 siRNA significantly attenuated the inhibition of TPA-induced MMP-9 protein expression and cell invasion by 15d-PGJ2. These results suggest that 15d-PGJ2 inhibits TPA-induced MMP-9 expression and invasion of MCF-7 cells by means of a heme oxygenase-1-dependent mechanism. Therefore, PPAR¥ã/HO-1 signaling-pathway inhibition may be beneficial for prevention and treatment of breast cancer.
KEYWORD
Heme oxygenase-1, MCF-7, MMP-9, PPAR¥ã, 15d-PGJ2
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø